Flow cytometry was utilized to quantify the proportions of splenic Th1, Th2, and Th17 cells (key immune cells implicated in anti-GBM GN) in both wild-type and USP25−/− mice 14 days post-induction of the anti-GBM GN model (Figure 2(A)). This evidence concerns the gene USP25 and glioblastoma.